Screening
Routine screening in the general population is not recommended.
In certain circumstances, medical surveillance programs may be implemented in a workforce at risk of sensitizer-induced occupational asthma (as part of secondary prevention). Typically these programs include a symptom questionnaire, skin prick testing or serum-specific immunoglobulin E (IgE; in the few situations when the sensitizer is a high molecular weight allergen and the tests are available), and spirometry.[22] The specific components of such programs that lead to any beneficial effect are unclear.
Use of this content is subject to our disclaimer